Drug Type Biosimilar, Fusion protein |
Synonyms Asfotase alpha Biosimilar (Generium ZAO), 阿司福酶α生物类似药(Generium ZAO), GNR-104 + [1] |
Target |
Action modulators |
Mechanism ALP modulators(Alkaline phosphatases modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hypophosphatasia | Preclinical | Russia | 01 Mar 2026 |






